Mondelez International, Inc. (NASDAQ: MDLZ) — Volume Is Turning Before Cocoa Reaches the P&L

Report date: 2026-08-21 Price (2026-08-20): $64.14 · Market cap: ~$81.9B · Enterprise value: ~$101.6B · Annualized dividend yield: ~3.2% · Five-year beta (AZI): ~0.07

⚡ Claude’s Take

This is the author.s independent subjective opinion, provided for general information only and not investment advice. The analytical body that follows carries no recommendation and no price target.

Verdict: HOLD around $64; accumulate on weakness below $60, with the high-$50s the more attractive entry zone. Medium conviction. The call is unchanged from 2026-06-13. On normalized 2027 earning power of roughly $3.05–$3.20 per share, a defensible 19–22x band implies a broad value zone of approximately $58–$70; today’s price sits in its middle, not at a dislocation. This is a quality-franchise/cyclical-recovery setup, not a falling knife and not a momentum chase.

Q2 supplied the missing operational evidence from June: consolidated volume/mix turned positive, North America returned to positive volume/mix, AMEA grew volume strongly, and the company says 65% of measured snack revenue is holding or gaining share. Cocoa has also retreated below the prior memo’s $6,000–$7,000 failure band. Those facts weaken the bear case that Mondelez permanently damaged its franchises by overpricing. They do not complete the bull case. Europe still posted negative price and volume, adjusted operating margin fell 120 basis points, expensive hedges delay spot-cocoa relief, and H1 free cash flow did not cover dividends plus repurchases. At roughly 21x the lower end of 2026 adjusted EPS guidance and only 3.8% below the trailing-52-week high, the stock already discounts a meaningful part of the recovery.

The cleanest framing is “volume first, margin later—if later arrives.” The balance of evidence improved without creating more margin of safety: the stock is only 1.8% above the June reference price, but the post-Q2 jump moved it back above all three major moving averages and near its recent high. Conviction: medium. The single bullish flip is two more quarters of positive volume/mix paired with a visible adjusted-gross-margin bridge toward the mid-30s and falling net debt. The bearish flip is renewed cocoa inflation or a relapse in Europe/US volumes while reinvestment continues to depress conversion.

📈 Stock Price Action — Five-Year Event Map

Over the trailing five years, MDLZ traveled from the mid-$50s in late 2021 to a $78.59 peak in April 2023, then fell to $51.20 in January 2026 before recovering to $64.14. The current price is 18.4% below the five-year high, 25.3% above the five-year low, and within a trailing-52-week range of $51.20–$66.65. Price facts come from the AZI daily price series through 2026-08-20, accessed 2026-08-21.

1. 2021–22: Price action behaved like a defensive staple during the reopening and early inflation shock. Pricing offset cost pressure, but the 2022 rate/dollar reset compressed the multiple even as nominal growth held.
2. Late 2022–April 2023: The move to $78.59 coincided with investor confidence that brands could pass through inflation without losing the earnings algorithm; it became the five-year valuation and price high.
3. 2023–24 transition: The retreat began before the full cocoa earnings impact because higher rates reduced the value of long-duration staples earnings and price-led growth raised elasticity questions.
4. 2025 drawdown: The cocoa shock became visible in reported margins and volumes. FY2025 GAAP gross margin fell to 28.4%, while volume/share erosion made the market question whether the damage was temporary. FY2025 Form 10-K, filed 2026-02-04, accessed 2026-08-21.
5. 2026 recovery: The stock bottomed at $51.20 on January 8 as cocoa expectations improved, then Q2 supplied the first positive consolidated volume/mix print of the recovery. The discrete post-earnings move supports an interpretation that the market cared more about demand repair than GAAP derivative gains.

Changes since 2026-06-13

The call is unchanged, but the evidence mix is better and the thesis is narrower.

• Volume recovery moved from promise to early evidence. Q2 organic revenue grew 2.2%, with consolidated volume/mix +0.7 points; H1 volume/mix was +0.1. Biscuits/baked snacks delivered +1.3 points of volume/mix and gum/candy +4.3, offsetting chocolate at -1.6. North America reached +1.2 and AMEA +5.2, while Europe remained -2.1. Q2 2026 Form 10-Q, filed 2026-07-28, accessed 2026-08-21.
• Share evidence improved, with a caveat. The company’s Nielsen/scanner scorecard says 65% of snack revenue held or gained share year to date, up from about 40% in 2025. That is breadth of covered revenue, not a weighted share-point change, and some emerging-market cells use company revenue where category data are unavailable. It is supportive, not conclusive. Q2 2026 presentation, dated 2026-07-28, accessed 2026-08-21.
• The revenue outlook rose, the earnings outlook did not. FY2026 organic revenue guidance moved from flat-to-2% to at least 2%; adjusted EPS remains flat-to-5% constant currency and free cash flow remains about $3B. Higher advertising, ERP, supply-chain, and geopolitical/logistics costs are absorbing better gross-profit dollars. Q2 earnings release, dated 2026-07-28, accessed 2026-08-21.
• Cocoa moved in the right direction but has not normalized economically. ICCO estimates a 48,000-tonne 2024/25 surplus after a 492,000-tonne deficit, with a 28.5% stocks-to-grindings ratio. Mid-July prices near $5,500 per tonne were far below the panic peak but still roughly twice the old norm; Mondelez’s prior hedges keep 2026 input costs elevated. ICCO statistics, accessed 2026-08-21; ICCO May 2026 bulletin summary, accessed 2026-08-21.
• Adjusted margin conversion is still the missing proof. Q2 adjusted gross margin improved 20 bps to 34.0%, but adjusted operating margin fell 120 bps to 13.1%. GAAP gross margin of 42.6% was flattered by an $827M commodity/FX derivative mark-to-market gain and should not be treated as the run rate. Q2 Form 10-Q.
• Capital allocation became more conservative, not yet better. H1 buybacks fell to $212M from $1.65B a year earlier, but net debt still rose modestly to about $19.7B. The dividend increased 4% to $0.52 quarterly. Amit Banati became CFO on July 1; CEO Dirk Van de Put adopted a 10b5-1 selling plan and sold 133,580 option shares on August 19 under that plan. Q2 Form 10-Q; CFO appointment Form 8-K, filed 2026-06-18.

1. Executive Summary

Mondelez International is a global snacking company with $38.5B of FY2025 revenue, led by biscuits/baked snacks (about 48% of sales) and chocolate (about 33%), and with roughly 40% of revenue in emerging markets. Its central assets are demand captivity around habitual, low-ticket brands—Oreo, Ritz, Cadbury, Milka, Toblerone, belVita, LU—and local scale in manufacturing, advertising, procurement, and route-to-market. The moat is real but bounded: U.S. biscuits and dense emerging-market distribution are strongest; European chocolate has shown that brand loyalty does not permit unlimited price gaps.

The June report’s core tension remains intact. Cocoa’s move from a historical $2,500–$3,000 per tonne to a panic peak above $12,000 collapsed FY2025 GAAP gross margin from 39.1% to 28.4% and drove reported EPS to $1.89, but adjusted EPS of $2.92 better captured underlying operations. The supply balance is now improving. ICCO estimates a small 2024/25 surplus, and spot prices have fallen materially. Yet inventories remain thin, 2026 hedges embed earlier high prices, and the company has not quantified enough of the 2027 cost bridge to treat a full margin recovery as fact.

Q2 materially improved the demand side. Revenue was $9.355B, up 4.1% reported and 2.2% organic; volume/mix was +0.7 points. Emerging markets delivered +4.4% organic and +1.6 points volume/mix, and North America delivered +3.4% and +1.2. Europe was the exception at -3.5% organic, with both price and volume negative. The resulting conclusion is more precise than June’s: the franchise is no longer reasonably described as company-wide price-only growth, but developed-market chocolate still faces an affordability and price-gap problem.

Earnings quality remains noisy. Q2 GAAP EPS of $1.20 and GAAP gross margin of 42.6% benefited from an $827M commodity/FX derivative mark-to-market gain. Adjusted EPS of $0.73 was flat reported and down 2.7% constant currency; adjusted operating margin fell 120 bps even as adjusted gross margin improved 20 bps. Advertising and consumer support, ERP implementation, supply-chain modernization, and Middle East/logistics costs explain much of the gap. That spending can be moat maintenance if share and physical units continue to improve; otherwise it is simply lower conversion.

The balance sheet is serviceable but constrains aggressive capital return. June 30 cash of $1.716B against roughly $21.45B of debt implies net debt near $19.73B, modestly above year-end. H1 free cash flow of $668M did not cover $1.287B of dividends and $212M of repurchases, although seasonality makes a half-year comparison imperfect and management still guides to roughly $3B for the year. Buybacks have slowed sharply, which is appropriate. The dividend’s 4% increase is affordable on full-year guidance, but debt reduction should have priority over another large acquisition.

At $64.14, filing shares imply an $81.9B equity value and approximately $101.6B enterprise value. Against FY2026 adjusted EPS guidance of roughly $2.92–$3.07 constant currency, the stock trades at about 20.9–22.0x before the company’s estimated $0.05 favorable FX translation. The valuation requires positive volume to persist and margin recovery to begin in 2027; it does not require a return to the most optimistic pre-cocoa earnings path. This body takes no position. The key monitoring sequence is straightforward: Q3/Q4 volume and share, 2027 cocoa coverage and adjusted gross margin, then net debt and cash conversion.

Executive verdict: The operating moat is repairing sooner than the income statement. Mondelez remains a high-quality franchise with average capital stewardship. Q2 weakens the bear case, but one quarter of positive volume and a small cocoa surplus do not prove normalized earnings. The current valuation embeds a substantial, though not complete, recovery.

2. Business Overview

What it is. Mondelez manufactures, markets, and distributes snacks in ~150 countries. It is the deliberate “snacking half” of the 2012 Kraft Foods split (the grocery half became Kraft Foods Group, later Kraft Heinz). Since then management has pursued a single strategic identity — “lead the future of snacking” — concentrating the portfolio on biscuits and chocolate and divesting non-core grocery, cheese, gum (developed markets), and coffee.

Category mix (FY2025). Roughly:

• Biscuits & Baked Snacks — ~48% of revenue. The crown jewel and the most durable franchise. Oreo, Ritz, belVita, LU, Chips Ahoy!, Triscuit, Wheat Thins, Tate’s Bake Shop, 7Days/Chipita (croissants), club/multipack formats. Cocoa-light, brand-defended, and in the US distributed through the legacy Nabisco direct-store-delivery (DSD) route network.
• Chocolate — ~33% of revenue. Cadbury Dairy Milk, Milka, Toblerone, Cote d’Or, Lacta, plus a premium push (Cadbury & More, Milka MAX, Toblerone Pralines, Hu). The cocoa-exposed book and the epicenter of the 2024–2026 margin story.
• Gum & Candy — ~10%. Trident, Halls, Sour Patch Kids, Stride, Ricolino (Mexico). MDLZ sold its developed-market gum business in 2023 to focus on emerging-market gum and candy.
• Cheese & Grocery / Beverages — ~6–9% combined, mostly Tang/powdered beverages and legacy positions in select markets.

Geographic mix and the emerging-market engine. MDLZ reports four segments: Europe, North America, AMEA, Latin America. Critically, emerging markets are ~40% of total revenue (all of Latin America; most of AMEA; Eastern Europe including Russia, Türkiye, Ukraine) and have compounded organically in the low-double-digits over five years — India, Brazil, China, and Mexico are the structural growth core, with snacking per-capita consumption still a fraction of developed-market levels. In Q1 2026, emerging markets grew +6.3% organic versus +0.8% for developed markets — the clearest signal of where the durable growth lives.

Segment profitability profile. The four geographic segments differ markedly in economics. Europe (~39% of revenue) is the largest and historically among the most profitable, but it carries the heaviest chocolate exposure (Milka, Cadbury, Toblerone, Cote d’Or) and therefore bore the brunt of the 2025 margin hit and the northern-European pricing missteps. North America (~28%) is overwhelmingly biscuits (Oreo, Ritz, belVita, Nabisco) and is the highest-margin, highest-cash-generation segment — management explicitly calls the US biscuit network and its DSD/profit pool a “competitive advantage”. Its volume was a major 2025 pressure point, but Q2 improved to +1.2 points of volume/mix. AMEA (~20%) and Latin America (~13%) are the emerging-market growth engines, lower-margin in absolute terms but higher-growth and increasingly important to the mix; AMEA produced +5.2 points of Q2 volume/mix. The practical implication for the thesis: the margin recovery story is mostly a Europe/chocolate story, while the volume/growth story is mostly an AMEA/LatAm story, with North America now showing an early turn — partly independent levers that make the consolidated franchise more resilient than a single-region chocolate maker.

How it makes money. Low-ticket, high-frequency, habitual/impulse consumables sold through every retail channel (grocery, mass, club, convenience, pharmacy, e-commerce, and traditional trade in emerging markets). Revenue is highly recurring and non-cyclical in volume terms — consumers keep purchasing Oreos and Cadbury through recessions. The 2024–2025 episode proved the business is volume-defensive but not margin-defensive against a concentrated input shock: a ~1,070bp single-year GAAP gross-margin collapse on a ~$38.5B base is one of the largest input-cost hits in modern staples history, and it came entirely from one commodity.

Recent trajectory (Q2 2026, reported July 28). Net revenue was $9.355B, up 4.1% reported and 2.2% organic. Pricing contributed 1.5 points and volume/mix 0.7. Emerging markets grew 4.4% organic with +1.6 points volume/mix; developed markets grew 0.7% with flat volume/mix. AMEA and North America were the cleanest positive reads, while Europe remained the weak link at -3.5% organic, including negative price and volume. Adjusted operating income and EPS were still down constant currency because management is reinvesting gross-profit progress rather than maximizing 2026 conversion. Q2 2026 Form 10-Q, filed 2026-07-28, accessed 2026-08-21.

The DSD edge, mechanically. In US biscuits, MDLZ inherited Nabisco’s direct-store-delivery system: its own trucks and route salespeople deliver to and merchandise the store shelf directly, rather than shipping to a retailer’s warehouse for the retailer to stock. DSD is expensive to run (it is the reason US biscuit margins carry a distribution-cost burden peers in warehouse-delivered categories avoid) but it buys three things competitors cannot easily replicate: control of shelf placement and display, freshness/speed-to-shelf (critical for an impulse category), and the ability to execute promotions and new-item launches in days rather than retailer-reset cycles. The strategic significance is that Kellanova and Nestlé have exited DSD in favor of warehouse delivery — so MDLZ’s relative advantage in the US cookie/cracker aisle has widened over the past decade even as the absolute cost has risen. Management is now modernizing this network (automating distribution centers, consolidating ~55 branches, AI-enabled fulfillment) to lower its cost while preserving the control advantage — a multi-year (2026–2029) program flagged at CAGNY and on the Q1-2026 call.

Brand economics. The portfolio is anchored by a handful of franchises that each clear or approach $1B+ in revenue — Oreo (>$4B globally), Cadbury, Milka, Ritz, belVita, LU, Toblerone, Trident, Halls — supplemented by a deliberately built “ventures” layer of higher-growth, better-for-you brands (Clif, Perfect Bar/Snacks, Grenade, Tate’s, Hu) acquired to give the portfolio exposure to protein/well-being and premium occasions. The economics of the core are classic branded-CPG: low unit cost, high purchase frequency, pricing power sufficient (in normal times) to pass through input inflation with a lag, and advertising/innovation as the maintenance capex of the brand. The 2024–2025 episode is the exception that tests the rule — when one input (cocoa) quadruples, even strong brands hit a price-elasticity wall, as the chocolate book demonstrated.

Verdict: A genuinely defensive, globally diversified, brand-led snacking franchise with a high-quality emerging-market growth engine and a distinctive US distribution moat — structurally sound, but with its profit pool currently distorted by an exogenous commodity shock concentrated in the chocolate third of the portfolio.

3. Industry Dynamics

Category size and growth. Commercial market estimates put global biscuits at $142.05B in 2026, growing 5.05% annually through 2031, and global chocolate at $127.1B in 2025, growing 4.9% annually from 2026 to 2033. These proprietary estimates are directional, not audited market definitions, but they corroborate large, durable categories with mid-single-digit nominal growth. Emerging-market per-capita consumption remains the longer-duration volume opportunity. Mordor Intelligence biscuits market, updated 2026-07-24, accessed 2026-08-21; Grand View Research chocolate market, accessed 2026-08-21.

Competitive structure — concentrated at the top. In biscuits, Mondelez is the uncontested #1 globally at ~17% share, multiples ahead of the next branded player; the rest of the field is regional brands, private label, and adjacency players (PepsiCo/Frito-Lay in savory, General Mills, Kellanova). In chocolate, the top five — Mars (~#1), Mondelez, Ferrero, Hershey, Nestlé — control roughly 38% combined; chocolate is more concentrated and more cocoa-exposed than biscuits. Private competitors (Mars, Ferrero) are formidable and not capital-market-constrained. Hershey is the dominant US chocolate player (~#1 US share) but is geographically concentrated.

The cocoa supply chain — the structural fault line. West Africa (Ivory Coast + Ghana) supplies ~60–65% of world cocoa. The 2023–2024 super-spike was driven by a genuine multi-year structural deficit: cacao swollen-shoot virus (Ghana lost ~1M hectares of productive trees), black-pod disease, aging tree stock, El Niño weather, illegal gold mining encroaching on cocoa land, and chronic under-investment because farmgate prices were historically too low to fund replanting. This matters for the thesis because it means cocoa’s elevation is partly structural, not purely cyclical — mean-reversion is slow (new trees take 3–5 years to bear) and may be only partial. The bullish counter, voiced by MDLZ management on recent calls, is that supply is now responding outside West Africa — Brazil (large farms, long-term supply agreements), Ecuador (smallholder cooperatives), and parts of Asia (India, Indonesia) are scaling output, which both lowers price and diversifies geographic risk. Management’s stated read is that cocoa has returned to “a much more representative” level and that 2027 will see “a significant uplift in chocolate margins.” A longer-dated wildcard management itself raised: lab-grown (non-GMO, cell-cultured) cocoa, which it expects regulators may eventually approve and which would structurally cap cocoa cost — speculative, but a real R&D direction across the industry.

Regulation. The EU Deforestation Regulation (EUDR) raises traceability and compliance costs for cocoa. The European Commission says it applies from December 30, 2026 for large and medium operators and covered micro/small timber operators, and June 30, 2027 for other micro/small operators. Broader HFSS marketing restrictions and sugar taxes remain market-by-market headwinds. None is thesis-breaking, but together they raise the cost of doing business in indulgent categories. European Commission EUDR implementation update, 2026-07-13, accessed 2026-08-21.

GLP-1 demand risk. The structural overhang question for all indulgent-snack makers. The evidence is genuinely mixed: some studies show GLP-1 users cutting calorie-dense snack spending ~10%, while premium-chocolate data (e.g., Lindt) shows GLP-1 users actually increasing premium chocolate spend. MDLZ models it quarterly and estimates that even at 10–20% US adoption over a decade the drag on its total volumes would be ~0.5–1.5% cumulative over ten years — i.e., near-negligible annually. That is management’s number and should be treated as a hypothesis, but the impulse/everyday-snacking and emerging-market skew of MDLZ’s portfolio makes it less exposed than, say, a US-centric salty-snack or sugary-beverage maker.

The broader health/wellness shift. Beyond GLP-1, indulgent snacking faces a slow secular nudge toward “better-for-you” — lower sugar, higher protein, cleaner labels, portion control. MDLZ’s response is twofold and pragmatic: (1) extend core brands into permissible variants (zero-added-sugar Oreo in China/US, gluten-free Oreo, portion/multipack architecture) and (2) own the trend directly via the ventures portfolio (Perfect Bar/Snacks and Clif Builders for protein, Grenade, Hu for premium-clean chocolate). This is defensive diversification rather than a growth bet — the core indulgent franchises remain the profit engine — but it signals management is not in denial about the demand drift, and the protein/well-being lines are among the faster-growing parts of the book (management cites double-digit growth for several). The risk is that these adjacencies are lower-margin and competitively crowded; the opportunity is that they keep MDLZ relevant to the health-conscious consumer it would otherwise cede.

Coffee exit. MDLZ historically held a large stake in JDE Peet’s (legacy of the Kraft/DE coffee combination). In late 2024 it sold the remaining JDE Peet’s stake to JAB for ~€2.16B, completing its exit from coffee and sharpening the pure-snacking identity. Net positive: it removes a non-core, lower-growth, separately-managed asset and frees capital.

The cocoa price path, with numbers. Cocoa (ICE/London futures) traded around its long-run norm of ~$2,500–3,000/tonne for most of the 2010s. The structural deficit drove it to ~$10,000–11,000 by early 2024 and a spike peak near $12,000/tonne in late 2024 — a roughly 4x move that is without precedent in the modern era of the contract. Through 2025 it remained punishingly high, then fell sharply in early 2026 as the West African mid-crop came in better than feared, demand (grindings) softened, and the speculative length unwound. On the Q1-2026 call management characterized a level around the ~$2,500–3,000 equivalent as “a much better representation of supply and demand,” noted the industry’s average forward coverage had stretched to a record ~10 months (which mechanically held futures up even as fundamentals loosened), and said it expects another year of supply surplus. The practical consequence for MDLZ: because it hedges/covers forward, its realized cocoa cost lags spot — 2026 is largely locked at a coverage price (~£4,800/t) above the falling spot, which is precisely why 2026 is a margin-trough year even as spot improves, and why the real margin relief lands in 2027.

Value chain and where the profit pool sits. The chocolate value chain runs farmer → cooperative/trader → grinder/processor (Barry Callebaut, Cargill, Olam) → brand manufacturer (MDLZ, Hershey, Nestlé) → retailer. In normal times the brand manufacturer captures the largest, most durable slice of the profit pool because the brand is the scarce asset; in a cocoa spike, the farmer/grinder slice temporarily fattens and the brand manufacturer’s margin compresses (it cannot fully or instantly pass through a 4x bean move without destroying volume). Biscuits have a shorter, less commodity-concentrated input chain (wheat, sugar, palm/vegetable oils, packaging, energy) — no single input dominates, so the biscuit profit pool is structurally steadier than chocolate’s. This is the core reason the memo treats biscuits as the higher-quality franchise.

Verdict — a structurally good industry with one acute, concentrated vulnerability. Biscuits and chocolate are attractive: large, growing, oligopolistic at the top, brand-defended, with a long emerging-market runway. The single structural weakness is the cocoa supply chain — geographically concentrated, disease-prone, slow to re-supply — which keeps the chocolate sub-segment’s economics impaired relative to its pre-2023 norm and injects real commodity volatility into an otherwise placid staples profile. On the Marathon capital-cycle lens, high cocoa prices should attract supply investment and mean-revert, but the multi-year biological lag (new trees take 3–5 years to bear, disease eradication is slow) means the cycle turns slowly and the supply response is only now arriving outside West Africa. Good industry; cost-impaired chocolate node.

4. Competitive Position

Name the moat. Mondelez’s advantage is a combination of demand-side brand intangibles + supply-side economies of scale + distribution density, in Greenwald’s taxonomy a customer-captivity (brand/habit) advantage reinforced by scale economics. Concretely:

1. Brand equity / habitual purchase. Oreo, Cadbury, Milka, Ritz, belVita, LU, Toblerone are century-old, top-of-mind, low-deliberation purchases with entrenched shelf presence. These are the kind of brands that survive private-label competition because the purchase is impulsive, emotional, and low-cost — the consumer doesn’t optimize. Oreo is a >$4B global brand; in China it holds ~18% of the entire biscuit category, its highest country share anywhere.

2. Scale economies in procurement, advertising, and manufacturing. At ~$38.5B revenue MDLZ buys ingredients, packaging, and media at a scale regional competitors cannot match, and amortizes brand-building and R&D across a global footprint.

3. Distribution density — the underappreciated edge. In emerging markets, MDLZ’s direct-distribution reach (adding tens of thousands of stores per year of direct coverage in markets like China and India) is a genuine, hard-to-replicate moat — getting product onto shelves in fragmented traditional trade is a decades-long build. In the US, the Nabisco DSD route network lets MDLZ control shelf placement, freshness, speed-to-shelf, and in-store display directly — and competitors (Kellanova, Nestlé) have exited DSD, widening MDLZ’s relative advantage in biscuits.

Does the moat show up in the numbers? Partially, and unevenly. The honest read is that the moat is real but bifurcated:

• Biscuits: strong, durable moat. #1 global share with a wide lead, cocoa-light cost structure, DSD advantage, brand-defended. This franchise earns its keep.
• Chocolate: a good brand portfolio in a structurally cost-impaired sub-industry, with a demonstrated pricing-power ceiling. Through the 2022–2024 inflation, MDLZ pushed price hard and the categories largely absorbed it. But the 2024–2025 cocoa spike forced chocolate list prices up so far that elasticity finally bit: Q4 2025 chocolate showed +20.8% price against −9.4% volume, and in the “northern” European markets (Germany, Nordics, UK) management openly admitted higher-than-expected elasticity and a flawed price-pack strategy that it is now correcting. Pricing power exists, but it is not infinite — and the 2025 episode marked where the ceiling is.

The market-share test. Mondelez failed Greenwald’s share-stability test modestly in 2025: net-revenue-weighted share declined as North American biscuits and developed-market chocolate absorbed price elasticity. Q2 2026 improved the evidence. The company’s scanner-data scorecard says 65% of snack revenue held or gained share year to date versus roughly 40% in 2025, and U.S. share improved across categories. The measure is breadth of covered revenue, not a weighted share-point change; some channels are excluded, and company revenue substitutes for unavailable category data in parts of emerging markets. The proper conclusion is improving, not proven. Q2 positive biscuit volume plus better share is what a resilient moat should produce after reinvestment, while Europe chocolate’s continued contraction shows that the moat remains bounded by affordability.

Private label. A persistent secondary threat, blunted in branded biscuits/chocolate by impulse purchasing and brand equity, but rising in value-seeking developed markets. The cocoa-driven ~20% branded price increases widened the gap to private-label and own-label chocolate, creating a real (if cyclical) share risk that recedes as branded pricing normalizes.

Applying the Greenwald tests explicitly. Bruce Greenwald’s framework says a genuine competitive advantage shows up as (a) stable or rising market share over time and (b) ROIC durably above the cost of capital. MDLZ passes (a) cleanly in biscuits (a wide, stable #1) but only marginally in chocolate (share slipped modestly in 2025 as it defended price). On (b), the operating business clears the bar but the capital base — bloated by ~$44B of acquisition-driven goodwill and intangibles — drags consolidated ROIC down to roughly WACC (Section 6). The Greenwald verdict is therefore nuanced: there is a real demand-side (brand/habit) advantage plus scale, strongest where the input is benign (biscuits) and tested where it is not (chocolate), but the returns that advantage generates have been diluted by the price paid for growth.

Numeric peer framing. Against the chocolate peer set, MDLZ is #2 globally behind Mars and ahead of Ferrero, Hershey, and Nestlé; in biscuits it has no global peer of comparable scale (PepsiCo’s Frito-Lay competes in adjacent savory snacking, not directly in sweet biscuits). The closest public comparison is Hershey — but Hershey is ~90%+ US, ~single-category chocolate-and-salty, and even more cocoa-concentrated, whereas MDLZ is ~76% ex-US with the biscuit diversifier and the EM engine. Nestlé is the diversified mega-cap with a broader portfolio (coffee, water, pet, nutrition) and lower snacking purity. The practical takeaway: MDLZ is the most geographically and category-diversified way to own global snacking, which is both its quality argument (resilience, EM growth) and the reason no single competitor threatens the whole.

Verdict — durable advantage in biscuits; good-but-cost-impaired franchise in chocolate. This is a real, multi-source moat, not a crowded commodity business. But the 2024–2025 stress test exposed that it is narrower than the 2019–2023 “unassailable compounder” narrative implied: chocolate has a pricing ceiling and cocoa-cost exposure, and the consolidated franchise lost a little share defending price. Own the biscuit moat with conviction; respect the chocolate franchise but price in its cyclicality.

5. Growth History and Forward Opportunities

The long-term algorithm. MDLZ targets 3–5% long-term organic net revenue growth plus high-single-digit-plus adjusted EPS growth and a growing dividend. Over 2021–2024 it generally met or exceeded the top-line algorithm — but the composition deteriorated.

Revenue trajectory (reported, ROIC/filing basis): $26.6B (2020) → $28.7B (2021) → $31.5B (2022) → $36.0B (2023) → $36.4B (2024) → $38.5B (2025). The 2022–2023 surge was heavily pricing-led (inflation pass-through) plus the Chipita/Clif/Ricolino acquisitions; reported 2024–2025 growth moderated as the gum/coffee divestitures and FX created offsets.

The critical tell — Q2 interrupted the price-only pattern. Decomposing organic growth into price vs. volume/mix:

• FY2024: organic ~+4.3%, volume/mix ~−1.0% (i.e., ~+5.3 price)
• FY2025: organic +4.3%, volume/mix negative (Q3 vol/mix ~−4.6%; Q4 chocolate −9.4%)
• Q1 2026: organic +3.0%, pricing +3.5%, volume/mix −0.5%
• Q2 2026: organic +2.2%, pricing +1.5%, volume/mix +0.7%; H1 volume/mix +0.1%

Three years of positive organic growth resting on negative volume/mix was the lowest-quality form of growth: it masked genuine volume erosion and modest share loss. Q2 is the first meaningful break in that pattern. Excluding an estimated 50-basis-point drag from package downsizing, management says consolidated volume/mix would have been about +1.2 points. Biscuits/baked snacks and gum/candy were positive; chocolate remained negative. This makes the recovery more credible but not yet durable. The central test is whether Q3 and Q4 remain positive after the Latin America SAP inventory pull-forward and favorable North American product mix wash through.

FY2026 guidance — better revenue, unchanged conversion. Management raised organic net revenue guidance to at least +2% from flat-to-+2%, while keeping adjusted EPS flat-to-+5% constant currency and free cash flow at about $3B. It also estimated July 17 exchange rates would add about two points to reported revenue and $0.05 to EPS. The non-raise on earnings is informative: advertising and consumer promotion, U.S. network modernization, SAP implementation, and Middle East/logistics costs are absorbing the stronger top line. Management continues to describe 2026 as a trough and 2027 as a strong-EPS-growth year, but has not provided a quantified 2027 bridge.

Growth engines, ranked by quality:

1. Emerging markets (~40% of revenue) — the highest-quality engine. India, Brazil, China, and Mexico combine under-penetration with distribution white space. Q2 emerging markets grew 4.4% organically with +1.6 points of volume/mix, and AMEA grew 7.1% with +5.2 volume/mix. India added more than 100,000 outlets year to date and Brazil reached roughly one million stores according to management. The reported volume validates direction; the store counts remain management claims to test through sustained regional growth.
2. Innovation / premiumization. The Biscoff partnership (biscuits + chocolate, scaling fast), Toblerone premium build, well-being (protein/fiber via Perfect Bar, Clif Builders, low-sugar Oreo variants), and cakes & pastries (Milka Croissant, 7Days extension into Brazil, Oreo cakes). Genuine, on-strategy, incremental.
3. M&A roll-up of snacking adjacencies. Chipita/7Days ($2B, 2021), Clif Bar ($2.9B, 2022, with a contingent earnout), Ricolino ($1.3B, 2022), Evirth (China cakes, 2024), plus Grenade, Hu, Tate’s, Give & Go, Perfect Snacks. The strategic logic is sound — acquire faster-growing adjacencies (croissants/cakes, performance-nutrition bars, premium/better-for-you, EM candy) at ~mid-to-high-single-digit category growth versus the ~3–4% core, and feed them through MDLZ’s distribution. The deals were struck at full branded-food multiples (the Clif Bar earnout is the tell that the price baked in performance hurdles), which is why (see Section 7) the program is strategically additive but financially value-neutral — it has lifted the growth of the portfolio without lifting its return on capital.

A note on the addressable runway. Per-capita snacking consumption gaps are the quantitative backbone of the EM thesis: chocolate and biscuit consumption per person in India, China, Brazil, and Africa remains a small fraction of Western Europe’s or North America’s. Even modest convergence, multiplied across populations in the billions and supported by MDLZ’s expanding direct-distribution reach (tens of thousands of incremental outlets per year in China and India), sustains the ~6%+ EM organic growth seen in Q1-2026 for years. This is the part of the story least dependent on cocoa and most dependent on continued local execution and currency stability.

Volume vs. price, in one table (organic growth decomposition):

The directional improvement culminated in Q2’s positive print. Emerging-market volume/mix was +1.6 points and AMEA +5.2; North America reached +1.2, driven principally by favorable product mix in biscuits. Developed-market volume/mix was flat, and Europe was -2.1. The evidence supports a real turn, but the physical-unit component is less robust than the consolidated headline and the regional dispersion remains wide.

Forward risks to growth: the frugal developed-market consumer (US basket flat for three years, down-trading to value/club/online channels); continued chocolate elasticity if cocoa stays high; GLP-1 (long-dated, modest per management); and HFSS/sugar regulation that constrains marketing and nudges reformulation.

Verdict — growth quality has moved from poor to improving. The 3–5% organic algorithm remains credible over a cycle because emerging-market distribution and category penetration are real volume levers. Q2 shows that company-wide price-only growth is no longer the right description. The proof standard is still higher than one quarter: positive H2 volume must survive mix, downsizing, SAP inventory timing, and European price-gap repair. The revenue outlook improved; the earnings algorithm has not yet reappeared.

6. Financial Quality

The headline distortion. FY2025’s GAAP statements are dominated by cocoa. Gross margin fell from 39.1% (2024) to 28.4% (2025); filing-basis operating margin from 17.4% to 9.2%; net income from $4.61B to $2.45B; and GAAP diluted EPS from $3.42 to $1.89 (−44.7%). Crucially, GAAP includes large unrealized mark-to-market swings on cocoa hedges, which exaggerate the move in both directions. On the adjusted basis (which defers unrealized commodity MTM until realized), adjusted EPS fell only 12.8% to $2.92 — the cleaner read on underlying earning power. Any valuation work must normalize off adjusted, not GAAP.

Q2 proves the distortion can reverse before the economics do. GAAP gross margin jumped to 42.6% and GAAP EPS to $1.20, but the quarter contained an $827M commodity/FX derivative mark-to-market gain, versus a $93M loss a year earlier. Adjusted gross margin was only 34.0%, up 20 bps, adjusted operating margin was 13.1%, down 120 bps, and adjusted EPS of $0.73 was flat reported and down 2.7% constant currency. H1 adjusted EPS of $1.40 was down 4.8% reported and 8.8% constant currency. The adjusted series is not perfect—hedging still moves realized costs across periods—but it is much closer to current operating economics than GAAP. Q2 2026 Form 10-Q; Q2 earnings release, accessed 2026-08-21.

Margin structure over time (ROIC/filing basis):

The pre-cocoa franchise ran a stable ~39% gross margin and ~16–18% operating margin — a high-quality consumer-staples profile. The 2022 dip was an earlier input-inflation wave (wheat/energy/dairy) that the company priced through within ~18 months, a useful precedent for the current episode. The 2025 trough is cocoa; the franchise’s normalized margin is the 2024 level, not the 2025 print.

Returns on capital. ROIC (ROIC.ai basis): 5.6% (2020), 7.3% (2021), 5.6% (2022), 8.4% (2023), 10.9% (2024), 5.8% (2025). ROE: 12.9% → 6.7% (2025). Two observations. First, the 2025 trough and 2024 peak both need normalizing (2024 was cocoa-flattered and divestiture-gain-aided; 2025 is cocoa-crushed) — the structural ROIC is roughly mid-single-digits to ~8–9%. Second, that range is uncomfortably close to (and in several years below) a reasonable WACC for a staples name — a direct consequence of the goodwill-and-intangibles-heavy balance sheet built through M&A (see Section 7). A high-quality operating business can still be a mediocre capital-return business when you pay full prices for acquisitions and carry ~$44B of goodwill+intangibles; MDLZ is exactly that.

Cash generation. Operating cash flow has been steady at ~$4.0–4.9B; 2025 OCF was ~$4.5B and company-defined free cash flow ~$3.2B. FCF comfortably funds the dividend (~$2.5B) but not the dividend plus the buyback (~$2.4B) — hence the incremental debt in 2025 (Section 7). One genuine quality marker: MDLZ runs a negative cash conversion cycle (~−35 days in 2025) — payables exceed inventory + receivables, so suppliers partly finance working capital, a structural feature of a powerful branded buyer. Current ratio is ~0.59, which looks alarming in isolation but is normal and healthy for a negative-working-capital consumer-staples model.

Balance sheet. At June 30, cash was $1.716B; short-term borrowings were $2.327B, current long-term debt $2.663B, and long-term debt $16.460B. Hand-built total debt is therefore about $21.45B and net debt about $19.73B, versus roughly $19.08B at year-end. Goodwill of $24.180B plus other intangibles of $19.509B equaled 61.3% of $71.247B of total assets; tangible book remains deeply negative. This is normal for an acquisitive branded-CPG company and not a solvency concern, but it makes book-value metrics uninformative and raises the cost of acquisition mistakes. The 2025 net-leverage spike was heavily an EBITDA-denominator effect, but first-half 2026 did not yet produce deleveraging. Debt-to-capitalization was 0.45 and long-term debt had a 6.8-year average term, supporting liquidity despite the elevated absolute burden. Q2 Form 10-Q.

Debt structure and ratings. The ~$21.8B of total debt (including ~$0.6B of finance leases) is termed out at a weighted-average maturity of ~7.3 years, with a ~$4.0B long-term financing authorization fully available and regular access to US and European commercial-paper markets for working-capital swings. MDLZ is a solidly investment-grade issuer (BBB/Baa tier); the principal rating sensitivity flagged in its own risk factors is that a downgrade would raise borrowing and commercial-paper costs. The maturity ladder is long enough that refinancing risk is modest even at ~3.8x trough leverage, and interest coverage of ~8.3x (down from 15.7x) remains comfortable. The combination — long maturities, CP access, IG rating, self-correcting leverage as EBITDA recovers — means the elevated leverage is a capital-allocation criticism (it was a choice, to fund returns into a trough) rather than a solvency concern.

Share count. Shares fell from 1.419B in 2020 to 1.276B outstanding on July 24, 2026, roughly a 10% five-year reduction. The current pace is much slower: first-half repurchases used $212M versus $1.653B a year earlier. June purchases of 3.456M shares averaged $60.69. Slower repurchases are rational while cash conversion and leverage are under pressure; the residual $6.5B authorization is capacity, not a commitment.

The negative-working-capital model, quantified. MDLZ’s cash conversion cycle is structurally negative (~−35 days in 2025, and as negative as ~−46 days in 2024). Mechanically: at year-end 2025 it carried inventory of ~$4.4B and receivables of ~$4.9B against accounts payable of ~$10.1B (plus ~$2.8B of accruals). Because a dominant branded buyer can dictate long payment terms to suppliers while collecting from retailers relatively quickly and turning inventory steadily, suppliers effectively finance the working capital of the business — a real, if unglamorous, structural advantage of scale that frees cash and is one reason FCF conversion is high despite moderate capex. The flip side is a current ratio of ~0.59, which is healthy in this model (not a liquidity warning) but would be alarming in a business without the supplier-financing dynamic.

FCF bridge and conversion. 2025 operating cash flow was ~$4.5B; after capex the company reported ~$3.2B of free cash flow. The gap between GAAP net income (~$2.45B) and OCF (~$4.5B) — a cash-flow-to-net-income ratio of ~1.8x — is the clearest single proof that the 2025 GAAP earnings depression is non-cash and commodity-driven (deferred/unrealized hedge effects, D&A, working-capital timing) rather than a deterioration in cash quality. Over a full cycle FCF conversion of net income runs near or above 1.0x, normal-to-good for branded staples. The one caution: the company-defined FCF (~$3.2B) covers the dividend (~$2.5B) but not the dividend-plus-buyback (~$4.9B total return) — the difference was debt-funded in 2025 (Section 7).

H1 cash conversion remains a watch item. H1 2026 operating cash flow was $1.322B and capex $654M, leaving $668M of simple FCF, down $150M year over year. Dividends of $1.287B plus $212M of repurchases exceeded that amount. Seasonality and commodity working-capital timing make the first half a poor annual run-rate; management still guides to about $3B. Even so, until second-half cash conversion closes the gap, capital return is partly balance-sheet funded.

Verdict — high-quality operating economics, still-unproven earnings normalization. Q2 volume and adjusted-gross-margin direction improved, but adjusted operating leverage and H1 cash conversion did not. The franchise can plausibly rebuild toward its historical economics as hedges roll; it has not yet done so. Goodwill-heavy invested capital and roughly $19.7B of net debt keep enterprise-level returns and capital flexibility merely average.

7. Capital Allocation

Dividend — the cleanest part of the story. The board raised the quarterly dividend 4% to $0.52 in July 2026, an annualized $2.08 and roughly 3.2% yield at the current price. The growth rate has decelerated from the historical high-single/low-double-digit pace as earnings and cash flow absorb cocoa. On FY2025 adjusted EPS of $2.92, the annualized payout is about 71%; on the low end of FY2026 guidance, it remains covered. The dividend is dependable, but the slower increase appropriately acknowledges the balance sheet.

Buybacks — now constrained, historically not valuation-sensitive. Share count fell about 10% over five years, but H1 2026 repurchases fell to $212M from $1.653B a year earlier, leaving $6.5B under the authorization. June purchases averaged $60.69. The slowdown is the correct choice while FCF and leverage are stretched. It does not erase the prior critique: 2025 buybacks were programmatic, outspent free cash flow alongside dividends, and were not obviously concentrated at the lowest prices.

M&A — strategically coherent, financially value-neutral. The bolt-on program (Chipita/7Days $2B, Clif Bar $2.9B, Ricolino $1.3B, Evirth, plus Grenade/Hu/Tate’s/Give & Go/Perfect Snacks — ~$10B+ deployed) is on-strategy: exit low-growth coffee and developed-market gum, then acquire higher-growth snacking adjacencies and emerging-market candy. But the financial verdict is value-neutral at best: ROIC has not improved despite the capital deployed, the deals were done at full multiples, the Clif Bar earnout was still being settled in 2025, and the balance sheet is now ~$44B of goodwill+intangibles with negative tangible book. The portfolio gardening is sensible; it has not compounded per-share value above what organic-plus-buyback would have delivered.

The sharpest critique — debt-funded returns into a trough, only partly corrected. In 2025 MDLZ returned roughly $4.9B to shareholders while FCF was about $3.2B, adding debt as EBITDA troughed. H1 2026 was more restrained on buybacks, but $668M of FCF still trailed $1.499B of dividends plus repurchases and net debt increased to roughly $19.7B. Full-year seasonality can repair the cash gap; the burden of proof is now on second-half conversion and deleveraging.

Incentives and succession. The proxy plan rewards organic revenue, adjusted profit/EPS, FCF, market share, and relative TSR, but contains no return-on-capital metric. CEO Van de Put earned about $24.5M in 2025 as combined Chair/CEO; say-on-pay received roughly 96% support. The CFO vacancy is now resolved: former Kenvue/Kellanova finance chief Amit Banati became CFO on July 1, while Luca Zaramella remains COO. Banati’s package includes a $1.05M salary, 125% target bonus, a $5M long-term award, and up to $7M of make-whole cash. Succession risk fell; the capital-efficiency incentive gap did not. CFO appointment Form 8-K, filed 2026-06-18, accessed 2026-08-21.

Insider signal. Van de Put adopted a Rule 10b5-1 plan on May 15, 2026, scheduled through May 2027. On August 19 he exercised 133,580 options at $42.11 and sold those shares at a weighted average $64.08 under the plan, retaining 1,326,488 directly owned shares. The scheduled nature reduces the signal, but the plan size and absence of recent discretionary code-P purchases provide no insider-confirmation of unusual undervaluation. Q2 Form 10-Q, Item 5; Form 4 filed 2026-08-21, accessed 2026-08-21.

Did M&A create value? The honest test. The cleanest way to judge a serial acquirer is whether ROIC rose as capital was deployed. It did not: across ~$10B+ of bolt-ons from 2021–2024, ROIC oscillated in a mid-single-digit-to-~8–9% band with no upward trend (the 2024 print was gain- and cocoa-flattered, the 2025 print cocoa-crushed). A second test — incremental returns — is muddied by the cocoa shock, but the structural point stands: the acquisitions were capitalized as ~$44B of goodwill and intangibles, indefinite-life brand impairments recur as a non-GAAP add-back, and the consolidated return on that swollen capital base hovers around the cost of capital. The deals bought growth and optionality (faster-growing categories, EM candy, better-for-you) and were strategically defensible, but they did not buy excess returns. A shareholder would have been roughly as well served by organic reinvestment plus buybacks — which is the definition of value-neutral M&A. The portfolio is better-shaped than it was in 2019; the per-share compounding is not measurably faster for the capital spent.

Portfolio simplification — the genuine win. The clearest capital-allocation positive of the last three years is subtraction: exiting developed-market gum (2023) and the entire JDE Peet’s coffee position (€2.16B from JAB, 2024) removed slower-growth, separately-managed, lower-synergy assets and refocused the company on snacking. Monetizing the coffee stake near the top of that asset’s value and recycling capital toward snacking adjacencies and shareholder returns was sensible, well-timed portfolio management — the mirror image of the value-neutral acquisitions, and evidence management can allocate well when divesting rather than pursuing more scale.

Verdict — a B-/B capital allocator, with better near-term restraint. The 2026 buyback slowdown and modest dividend increase are appropriate. The longer record remains average: coherent but ROIC-neutral acquisitions, good portfolio exits, programmatic repurchases, and no capital-efficiency metric in compensation. Deleveraging—not another large deal—is the highest-return use of marginal cash until normalized EBITDA is visible.

8. Changes and Headwinds — Last Two Years

1. Cocoa shifted from super-spike to delayed relief. The 2025 margin collapse still dominates the two-year record, but ICCO now reports a small surplus and July prices were near $5,500/tonne. The accounting lag matters: high-cost hedges keep 2026 realized inputs elevated, so lower spot creates a 2027 possibility rather than current earnings.

2. Volume recovery arrived unevenly. Q2 consolidated volume/mix turned +0.7 and North America +1.2, while Europe remained -2.1 and chocolate -1.6. The company-wide “price-only” diagnosis is stale; the narrower Europe/chocolate elasticity problem is current.

3. Two rejected Hershey bids and a $9B buyback (Dec 2024). A second rebuffed attempt at transformational scale; capital redirected to programmatic buybacks.

4. JDE Peet’s / coffee exit completed (€2.16B from JAB, Nov 2024; +$169M follow-on payment 2025). Portfolio simplified to a snacking pure-play.

5. CFO succession resolved. Amit Banati became CFO July 1 and Zaramella remains COO. Van de Put still combines Chair and CEO, so the board’s Lead Independent Director remains the principal counterweight.

6. Regulatory build-up. EUDR (cocoa deforestation traceability), CSDDD, HFSS/sugar taxes, and US tariff/trade uncertainty — rising compliance cost, none thesis-breaking.

7. Russia. MDLZ still operates in Russia (>2,500 employees; new capex/advertising suspended but operations continued), at ~3.7% of 2025 revenue (~$1.4B), with profitability “above historic levels.” Ongoing boycott/reputational risk plus a low-probability expropriation/deconsolidation tail.

8. Restructuring, ERP, and supply-chain execution. A new program began in Q4 2025 after Simplify to Grow. Latin America Q2 organic growth included about 1.5 points of customer inventory ahead of a mid-Q3 SAP S/4 implementation, creating a likely timing reversal; U.S. network modernization adds cost and execution risk.

9. Middle East conflict became a cost issue, not a revenue-concentration issue. Countries directly affected represented less than 1% of Q2 revenue, and the filing says operations had not been materially affected. Management nevertheless incorporated logistics and other conflict costs into the unchanged EPS outlook. Q2 Form 10-Q.

The competitive-reaction wildcard for 2026. A subtle but important dynamic management flagged repeatedly: because most of the chocolate industry covered 2026 cocoa needs forward at higher prices, and spot has since fallen, there is a window in which a competitor who is either less-covered or willing to absorb margin could cut shelf price to grab share, forcing MDLZ to follow and compressing the very margin recovery the thesis depends on. Management built “flexibility” into 2026 guidance precisely for this reason and said it does not intend to match aggressive price cuts it has seen floated by at least one peer. This is the near-term game-theory risk: the cocoa relief is real, but how the oligopoly shares that relief (pass it to consumers via lower price, or retain it as margin) is not yet settled and will be visible in 2026 promotional intensity.

Verdict — the last two years damaged reported economics but not the core franchise; Q2 supplied the first repair evidence. CFO uncertainty is resolved, volumes improved, and cocoa moved favorably. Margin conversion, Europe, leverage, and the industry’s allocation of cocoa relief between price and profit remain unresolved. The thesis is stronger than in June, but not complete.

9. Risk Analysis

Risk concentration read. Cocoa still drives the highest-impact risks, but Q2 clarified the transmission mechanism. Spot can fall while realized input costs remain high; gross margin can improve while operating margin falls because relief is reinvested; and consolidated volume can turn positive while Europe remains weak. Monitoring only cocoa is therefore insufficient. The three linked indicators are 2027 hedge coverage, Europe/chocolate physical demand, and adjusted operating conversion. ERP and cash-flow timing are medium-probability execution risks; GLP-1 and regulation remain slow-burn structural issues.

Catastrophic-loss risk: low. A diversified global staples franchise with #1/#2 category positions, recurring consumption, and an investment-grade balance sheet. The realistic bear case is multi-year earnings stagnation if cocoa stays elevated and elasticity caps pricing, not impairment of the franchise. Total-loss risk: negligible.

10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation. This section diagnoses the operating expectations embedded in the current capitalization.

Filing-built capitalization and trailing bridge

The report hand-builds market capitalization and enterprise value rather than using an aggregator. At the August 20 close of $64.14, the Q2 filing’s 1,276,308,057 shares imply $81.862B of equity value. Adding $21.450B of debt and subtracting $1.716B of cash produces $101.596B of enterprise value. The company’s debt and cash are dated June 30; the share count is dated July 24. Q2 Form 10-Q; AZI price CSV, accessed 2026-08-21.

Trailing figures use FY2025 plus H1 2026 less H1 2025, avoiding the error of annualizing a seasonally uneven first half.

The improved GAAP P/E is partly an accounting mirage. Q2 GAAP operating income included an $827M derivative gain, while adjusted operating income fell 4.8% and adjusted EPS was flat. The 22.5x adjusted multiple, 16.4x EV/adjusted EBITDA, and 3.77% cash-flow yield are more informative. They describe a franchise priced for recovery, not a trough cash annuity.

FY2026 adjusted EPS guidance provides a second lens. Flat-to-5% constant-currency growth from $2.92 implies approximately $2.92–$3.07 before the company’s estimated $0.05 favorable FX translation. The current price is therefore about 20.9–22.0x the constant-currency range. H1 constant-currency adjusted EPS was $1.34; the range requires roughly $1.58–$1.73 in H2, or 9%–19% year-over-year growth. Reaffirming guidance is an acceleration commitment, not evidence the acceleration has already occurred.

Corrected reverse cash-flow hurdle

The June report’s shortcut—that roughly 3.5%–4% perpetual FCF growth supported the enterprise value—was too permissive. It mixed enterprise value with an equity-style cash-flow proxy and skipped an explicit recovery stage. A corrected equity reverse-cash-flow model starts with $3.085B of trailing OCF less capex and the $81.862B equity capitalization.

Assumption: This is a diagnostic sensitivity, not a forecast. It does not assume current working capital is permanently depressed or favorable. Under the central 8.0%/2.5% assumptions, the capitalization requires about 10.8% annual cash-flow growth for five years, reaching $5.14B. That is materially more demanding than the long-run 3%–5% organic-sales algorithm because the starting cash yield is low. The market is underwriting margin normalization, cash conversion, and some per-share benefit—not merely stable revenue.

Operating scenarios—no share-price outputs

The central case is a four-link conversion. Lower physical cocoa must become lower realized COGS after hedge lags; COGS relief must become gross-profit dollars; gross-profit dollars must become adjusted operating income despite higher advertising; and earnings must become cash despite working capital and capex. Missing any link can produce favorable cocoa headlines without satisfying the valuation.

Peer and own-history context

The peer set is hierarchical, not mechanical. Hershey is the closest cocoa/chocolate comparison but is U.S.-concentrated; PepsiCo is the closest current factor twin and a route-to-market comparison but includes beverages; General Mills and Kraft Heinz are slow-growth packaged-food valuation floors.

Mondelez deserves a premium to GIS/KHC only if emerging-market distribution and global brands produce durable volume and cash growth. The spread over PEP requires a cleaner path from cocoa relief to margins despite PepsiCo’s own North American weakness. MDLZ’s multiple is roughly equal to Hershey’s despite lower chocolate concentration; that is defensible only if its diversified growth converts into cash.

AZI’s current valuation index could not be refreshed because the environment lacked AZI_API_TOKEN. The last valid June 12 reading—P/E 89.2nd percentile, P/B 85.0th, P/S 21.5th, composite 65.2nd—is therefore a dated fact, not a current percentile. The P/E rank was distorted by depressed GAAP EPS. Filing-built price/sales is 2.06x today versus approximately 2.08x in that June feed, so the low own-history sales-multiple signal is directionally intact; no claim is made that the percentile itself is unchanged.

Valuation verdict: The current capitalization embeds a meaningful recovery in cash generation. It does not require a return to the most optimistic pre-cocoa outcome, but it leaves little room for flat $3B cash flow, persistent Europe weakness, or cocoa relief that is entirely competed/reinvested away. The most relevant multiple is adjusted earnings and the most relevant falsifier is cash flow—not GAAP P/E.

11. Variant Perception

Consensus belief. Mondelez is a high-quality defensive snacking franchise passing through a transitory cocoa shock. Volumes are beginning to recover; cheaper cocoa reaches the P&L with a lag; 2026 is the trough and 2027 restores the long-run algorithm. Q2 supplied the first strong piece of evidence for that view.

What consensus now has right. Consolidated and North American volume/mix turned positive, AMEA volume was strong, measured share breadth improved, the physical cocoa balance is better, and management raised the revenue floor. These are not merely narrative points: they appear in the filed organic bridge and official market-data presentation. The broad bear claim that Mondelez is permanently a price-only grower is no longer supported.

What consensus may underprice. The cash hurdle is larger than the cocoa narrative implies. A 3.77% trailing cash-flow yield and 22.5x adjusted earnings require several billion dollars of additional annual cash generation over time. Europe remains negative on both price and volume; H1 adjusted operating margin fell 210 bps; net debt rose in dollars; and management did not lift EPS guidance when it lifted revenue guidance. Better cocoa supply is necessary but not sufficient.

Strongest favorable case. Q2 volume, rising measured share breadth, India/Brazil distribution, and higher brand investment are the early evidence of a self-reinforcing recovery. Cocoa supply improves while hedge rolls delay only the timing, not the direction. Mondelez retains enough relief to rebuild adjusted operating margin, EM growth offsets mature-market sluggishness, cash flow passes $5B over the explicit recovery period, and leverage falls without sacrificing the dividend. Under Greenwald, demand captivity and local scale are confirmed by restored share and returns; under Marathon, current restrained asset growth avoids competing away the benefits through new acquisitions.

Strongest skeptical case. The cocoa balance improves partly because grindings/demand weakened, inventory remains thin, and new biological supply takes years. Competitors and retailers force lower shelf prices and promotion, so cocoa relief funds the consumer rather than shareholders. Europe’s negative price and volume persist; North American volume requires enough advertising and mix support that segment profit does not grow; cash remains near $3B; and compensation still rewards adjusted growth without ROIC. The stock then remains a premium multiple on a slow-growth cash stream.

Factor-positioning read

The tape is a defensive/value/dividend recovery, not a crowded Momentum-factor trade. The August all-factor model explains 56.3% of return variance and shows active exposure to Consumer Staples (+0.845), Market (+0.435), Defensive Staples Stability (+0.298), Low Volatility (+0.209), Food & Beverage (+0.190), and Dividend Yield (+0.176), with negative Growth (-0.258) and Beta Factor (-0.412). Momentum and Quality were zeroed by the sparse model rather than missing. FactorsToday loadings, accessed 2026-08-21.

Raw returns were +5.2% over three months and +11.3% over six months. FactorsToday’s published m3/m6 returns are annualized; de-annualized values of +5.19% and +10.98% reconcile to the AZI series. The price is above the 21/50/200-day EMAs, but the five-year annualized return is only 2.94%, the three-year return -0.93%, and the five-year maximum drawdown 29.1%. This is no longer a falling knife, but the long-term record has not re-established compounder status. FactorsToday leaderboard; AZI price CSV.

Factor-similar names reinforce the classification: PEP similarity is 0.954, GIS 0.868, and KHC 0.853. Hershey is the closer economic cocoa peer but not the closest current factor twin. The distinction matters: MDLZ currently trades like a low-volatility staple with a recovery catalyst, not like a high-momentum chocolate trade.

Assumptions that matter and falsification

1. Volume durability. Q2’s +0.7 points must persist after mix, downsizing, and Latin America inventory timing. Two additional positive quarters with stable/rising share would validate the turn; renewed negative volume would refute it.
2. Europe repair. Price-gap correction must move Europe volume toward flat without destroying gross-profit dollars. Continued negative price and volume refutes a broad demand recovery.
3. Cocoa-to-margin conversion. Lower spot must reach realized COGS and survive promotion/reinvestment. A higher adjusted gross margin with still-falling operating margin is only partial progress.
4. Cash conversion. FY2026 must approach the $3B guide, then build toward the reverse-model hurdle. Persistent cash near $3B refutes the current valuation’s central recovery assumptions.
5. Capital discipline. Net leverage must fall below roughly 3x before buybacks accelerate or a large deal appears. Dollar net-debt growth despite recovered EBITDA would refute the deleveraging case.

Variant verdict: The market is probably right that the franchise is repairing and cocoa is less threatening than in 2025. The variant question is whether that repair earns enough incremental cash to justify the starting yield. Volume supplied the first pass; Europe, margin, cash, and leverage have not.

12. Fact vs. Interpretation

13. Open Questions

1. Cocoa reconciliation: What crop year, inventory/loss adjustment, and forecaster underlie management’s at-least-500kt surplus versus ICCO’s public 48kt 2024/25 estimate?
2. Hedge economics: What proportion of 2027 cocoa needs is covered, at what effective price, and in which quarters will lower costs enter COGS?
3. Physical demand: How much of Q2’s +0.7 volume/mix was actual units versus product mix; what is the effect of downsizing by category and region?
4. Share quality: What are revenue-weighted share-point changes behind the “65% holding/gaining” breadth statistic, including channels outside scanner coverage?
5. Europe: Can price-gap repair generate positive chocolate volume while preserving gross-profit dollars, or will relief be passed to consumers?
6. North America: Does positive volume persist while segment operating income turns positive, or is reinvestment merely renting share?
7. Cash conversion: Can H2 produce the required $2.332B of FCF and FY2026 approximately $3B without another increase in net debt?
8. Capital allocation: Will management commit to sub-3x net leverage before accelerating repurchases or pursuing a material acquisition?
9. Clif: Does the $156M contingent-consideration liability versus a $2.4B maximum indicate continued underperformance, and what are the actual deal-level returns?
10. 2027 bridge: How do cocoa, productivity, advertising, ERP, supply-chain, mix, FX, and volume combine into the promised strong adjusted-EPS growth?

14. What Must Be True

Bull case requirements

Bull-case interpretation: The volume checkpoint passed earlier than expected, which is meaningful. The thesis still requires cocoa-to-margin-to-cash conversion and deleveraging. A favorable commodity chart without those outcomes is not enough.

Bear case requirements

Bear-case interpretation: The broad price-only-franchise argument should be retired. The narrower bear case—Europe chocolate elasticity, structurally elevated cocoa, reinvestment-heavy conversion, and average capital stewardship—remains live.

Source appendix follows in Appendix B (separate file).

APPENDIX A — Standard Diligence Questionnaire

Mondelez International, Inc. (NASDAQ: MDLZ) — as of 2026-08-21

Supplemental to the research memo. Labels: FACT / INTERPRETATION / ASSUMPTION where material.

General

What thoughtful questions have other investors asked about this company? The dominant Q2 questions cluster around: (1) whether positive volume/mix is physical-unit recovery or favorable mix and downsizing; (2) why higher organic-sales guidance did not raise adjusted-EPS guidance; (3) when lower spot cocoa reaches realized costs; (4) whether Europe chocolate can repair price gaps without surrendering gross-profit dollars; (5) whether 2027 “strong EPS growth” can be quantified; and (6) whether cash conversion and leverage permit buybacks. The sharpest unresolved mismatch is management’s at-least-500kt cocoa-surplus view versus ICCO’s latest public 48kt 2024/25 estimate.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? A cyclical low on an adjusted basis. Q2 GAAP earnings swung high because of an $827M derivative gain, while adjusted EPS was $0.73 and down 2.7% constant currency. Management still describes 2026 as the trough with a 2027 inflection. (INTERPRETATION: normalized earning power is above the current adjusted run rate, but the size and timing of recovery are not established.)

Driven by external environment or company actions? Predominantly external (cocoa commodity prices, FX, the frugal consumer), amplified modestly by execution missteps (an admitted flawed European chocolate price-pack strategy).

How stable are revenues? Revenue is defensive because purchases are low-ticket and habitual, but physical demand is not invariant to price. Q2 organic growth was +2.2% and volume/mix +0.7; H1 volume/mix was only +0.1. Europe remained negative, while AMEA and North America improved.

Outlook for products/services? Structurally favorable — global biscuits and chocolate grow ~4–4.5% with emerging-market tailwinds and premiumization. Near-term clouded by cocoa and developed-market consumer softness.

How big will this market be — growing, shrinking, domestic or international? Large and growing: global biscuits ~$125–140B and chocolate ~$130–150B, each ~4%+ CAGR. ~76% of MDLZ revenue is ex-US; ~40% is emerging markets — heavily international and structurally growing.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Broadly stable oligopoly at the top (Mars, Mondelez, Ferrero, Hershey, Nestlé in chocolate; Mondelez dominant in biscuits). Competitive intensity rose temporarily as cocoa forced large branded price increases, widening gaps to private label.

How profitable is the business (ROIC, ROE)? Normalized ROIC ~8–9% (mid-single-digits in trough/peak-distorted years; 5.8% in 2025, 10.9% in 2024); normalized ROE ~13–15% (6.7% in 2025 trough). (INTERPRETATION: operating economics are good but structural ROIC sits only around WACC because of the goodwill-heavy, M&A-built balance sheet.)

How profitable is the industry — how many competitors, what barriers to entry? High barriers in branded snacking: brand equity, scale in procurement/advertising, distribution density (DSD in US; direct reach in EM), shelf control. Top-5 chocolate ~38% share; biscuits MDLZ ~17% #1. Genuinely defensible.

Can the business be easily understood? Yes — sell branded biscuits and chocolate globally; the one variable to master is cocoa.

Can it be undermined by foreign low-cost labor? No — brand, distribution, and freshness/logistics dominate; this is not a labor-cost-competed business.

Do brands matter? Decisively — Oreo (>$4B), Cadbury, Milka, Toblerone, Ritz, belVita, LU are the core asset. Brand equity is the primary moat.

What is the nature of competition? Brand-vs-brand for shelf space and consumer habit, plus price-pack architecture and innovation; private label is a secondary, downturn-sensitive threat.

Customers’ switching costs? For the retail consumer, low monetary but high habitual/emotional switching friction (impulse, low-deliberation purchase). For retailers, MDLZ’s must-stock brands and DSD service create real stickiness.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes — organically built brand equity and the global distribution network are worth far more than book; conversely, indefinite-life intangibles ($19.6B) and goodwill ($24.3B) carry impairment risk.

Off-balance-sheet liabilities? Standard operating leases (capitalized), pension obligations (~$0.5B), and the live Clif Bar contingent earnout. Nothing unusual disclosed.

How conservative is the accounting? Mixed. The adjusted/GAAP gap is large but mechanically driven by commodity-hedge MTM and divestiture gains/impairments rather than aggressive revenue recognition. The frequent non-GAAP add-backs (impairments, restructuring, MTM, hyperinflation remeasurement) warrant scrutiny but are well-disclosed and largely defensible.

How CapEx-hungry is the business? Moderately — packaged-food manufacturing plus the current US supply-chain modernization and ERP build; capex runs a few percent of sales, comfortably below operating cash flow.

Capital Allocation & Management

How much FCF does the business generate, and how is it used? FCF was about $3.2B in 2025; FY2026 guidance is about $3B. H1 2026 OCF of $1.322B less $654M capex yielded $668M, below $1.287B dividends plus $212M repurchases. Seasonality can close part of the gap, but deleveraging should outrank accelerated repurchases or new large M&A.

Significant acquisitions recently? Yes — Chipita/7Days ($2B), Clif Bar ($2.9B), Ricolino ($1.3B), Evirth (China cakes, 2024), plus smaller tuck-ins. Strategically coherent, financially ROIC-neutral. Divested developed-market gum (2023) and the JDE Peet’s coffee stake (€2.16B, 2024).

Buying back shares? Yes, but much less. H1 repurchases were $212M versus $1.653B a year earlier; 1.276B shares were outstanding on July 24 and $6.5B remained authorized. The restraint is appropriate.

Issuing large amounts of new shares to insiders? No — SBC is modest (~$0.1–0.15B/yr); net share count is falling.

Compensation policy of directors/management? CEO Van de Put ~$24.5M (2025), CFO/COO Zaramella ~$9.7M; incentives tied to organic revenue, adjusted gross/operating-income and EPS growth, FCF, market-share overlay, and relative-TSR modifier. (INTERPRETATION: well-supported (~96% say-on-pay) but contains no return-on-capital metric — the structural reason ROIC-neutral M&A persists.)

Motivations of management? Growth- and scale-oriented, cash-return-disciplined, but not demonstrably capital-efficiency-focused. The CFO search is resolved: Amit Banati started July 1 and Zaramella remains COO. Van de Put remains combined Chair/CEO and adopted a 10b5-1 selling plan; scheduled sales are a limited conviction signal, not proof of bearishness.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — common stock, NASDAQ-listed, standard 1099 dividend reporting.

Dividend policy? Quarterly cash dividend of $0.52 after a 4% July increase, $2.08 annualized and about a 3.2% current yield. The payout is roughly 71% of FY2025 adjusted EPS.

How profitable is the business? Normalized gross margin ~39%, operating margin ~16–18%, net margin ~13% — good staples economics, temporarily crushed to 28%/9%/6% in the 2025 cocoa trough.

Is net income diverging from cash from operations? Yes, in both directions across hedge cycles. FY2025 OCF exceeded GAAP net income because GAAP contained adverse non-cash marks; Q2 2026 GAAP income was flattered by a large favorable mark that did not produce matching cash. H1 FCF was only $668M. Adjusted earnings plus full-year cash conversion are the appropriate pair.

Risks & Downside

What factors would cause the stock to decline? A cocoa re-spike or failure to normalize; persistent volume/share loss proving the pricing-power ceiling is structural; a credit downgrade if leverage stays elevated; a value-destructive large acquisition; a sharp EM/FX shock; or a GLP-1 demand surprise.

Risk of a catastrophic loss? Low — diversified global staples franchise, investment-grade, recurring consumption. The realistic bear case is multi-year earnings stagnation, not impairment.

Chance of a total loss? Negligible.

Recent News & Events

Has the business environment changed recently? Yes. Cocoa is far below the panic peak, ICCO’s balance has moved to a small surplus, Q2 consolidated volume turned positive, and the company raised organic-sales guidance. Lower spot is not yet lower realized cost, Europe remains weak, and Middle East logistics add cost.

Significant acquisitions? Evirth (China cakes, Nov 2024) most recent; JDE Peet’s coffee stake sold to JAB (€2.16B, late 2024).

Change in accounting policies? None material; ongoing non-GAAP framework (commodity MTM, hyperinflation remeasurement) unchanged.

Recent changes — new markets, facilities, management? U.S. supply-chain/DSD modernization continues; SAP S/4 implementation created a Latin America inventory pull-forward ahead of Q3; Banati became CFO; the dividend rose 4%; repurchases slowed. India added more than 100,000 outlets year to date and Brazil reached roughly one million stores according to management, a claim to validate through sustained regional volume.

APPENDIX B — Source Appendix

Mondelez International, Inc. (NASDAQ: MDLZ) — research as of 2026-08-21

Sources are ordered primary-first. Quantitative figures were reconciled to filings where possible. Third-party price, transcript, valuation, and factor tools are cross-checks rather than accounting authority. Unless otherwise stated, links were accessed 2026-08-21.

1. Primary — SEC filings and company materials

The trailing-60-month EDGAR corpus was refreshed through 2026-08-21 and mirrored locally under output/MDLZ/sources/: 286 documents plus MANIFEST.csv. The local integrity check matched files to mirrored manifest rows.

• Q2 2026 Form 10-Q, filed 2026-07-28 — revenue; organic price/volume bridges by region and market type; GAAP and adjusted margins; cash flow; debt; derivatives; 10b5-1 plan; Middle East exposure; share count and repurchases.
• Q2 2026 earnings release, dated 2026-07-28 — adjusted results, raised organic-sales outlook, maintained EPS/FCF guidance, dividend increase.
• Q2 2026 presentation, dated 2026-07-28 — category volume/price, share breadth, Nielsen/scanner coverage limitations, regional scorecards.
• Q2 2026 prepared remarks, dated 2026-07-28 — distribution, advertising, innovation, Europe/US operational hypotheses, 2027 framing. Forward statements are treated as hypotheses.
• FY2025 Form 10-K, filed 2026-02-04 — $38.537B revenue; category/geographic mix; FY2025 GAAP/adjusted results; debt; Russia; cocoa, EUDR/CSDDD/HFSS and operating risks; restructuring and buyback authorization.
• FY2026 DEF 14A, filed 2026-04-03 — executive pay, annual/long-term incentive metrics, ownership, board structure and capital-allocation incentives.
• CFO appointment Form 8-K, filed 2026-06-18 — Amit Banati appointment, Luca Zaramella role, compensation and make-whole arrangements.
• CEO Form 4, filed 2026-08-21 — 133,580 option exercises and same-day planned sales on 2026-08-19; retained direct ownership. Mirrored raw XML in output/MDLZ/sources/4/ and available through the SEC company filings page.
• Five-year Form 3/4/5 corpus — transaction-code scan distinguished discretionary code-P purchases from grants, exercises, tax withholding, and sales. No recent discretionary open-market purchase was identified.

2. Primary / first-party — earnings-call evidence

• Q2 2026 earnings call, 2026-07-28 — retrieved through ROIC.ai get_latest_earnings_call using NASDAQ:MDLZ; used for management’s 2027 framework, distribution, channel, Europe/US, Middle East, and cocoa-supply commentary. Statements were cross-checked to the 10-Q, release, presentation, and prepared remarks above.
• Q4 2025 and Q1 2026 calls, 2026-02-03 and 2026-04-28 — baseline cocoa coverage, European chocolate elasticity, GLP-1 sensitivity, supply-chain modernization, reinvestment, and FY2026 trough framing.
• Mondelez quarterly-results archive — first-party hub for releases, slides, prepared remarks, and webcast materials.

Tool caveat: ROIC.ai list_earnings_calls failed open to unrelated companies despite the exchange-qualified identifier; the issuer identity was verified inside get_latest_earnings_call. Later enterprise-value calls required reauthentication, so the report hand-builds market cap and EV from filing shares, debt, cash, and the latest price.

3. Industry and commodity sources

• International Cocoa Organization statistics and May 2026 Quarterly Bulletin summary — 2024/25 production 4.723Mt, grindings 4.628Mt, 48kt surplus, 1.320Mt ending stocks, and 28.5% stocks/grindings. ICCO notes that estimates are revised as data mature.
• ICCO Quarterly Bulletin documentation — methodology and bulletin access.
• ICCO daily cocoa-price statistics — mid-July 2026 dollar and sterling price checks.
• Mordor Intelligence biscuits market, updated 2026-07-24 — proprietary $142.05B 2026 market estimate and 5.05% 2026–31 CAGR; directional only.
• Grand View Research chocolate market — proprietary $127.1B 2025 estimate and 4.9% 2026–33 CAGR; directional only.
• European Commission EUDR update, dated 2026-07-13 — application dates and cocoa coverage.
• Mondelez’s Cocoa Life, regulatory, and sourcing disclosures in the FY2025 10-K — EUDR/traceability and supply-concentration context.

Unresolved reconciliation: Management referred on the Q2 call to a cocoa surplus of at least 500kt and industry coverage around ten months. ICCO’s latest public 2024/25 estimate is 48kt; the difference may reflect crop year, private forecast, loss adjustment, or definition. The report uses ICCO as the established fact and labels management’s larger figure as a scenario.

4. Quantitative market and factor cross-checks

• AZI MDLZ daily price CSV, through 2026-08-20 — adjusted/unadjusted OHLCV, dividends, 21/50/200-day EMAs, beta and alpha. Used for the five-year event map and current price.
• FactorsToday stock-info/MDLZ, stock-loadings/MDLZ, leaderboard/MDLZ, and related-stocks/MDLZ, accessed 2026-08-21 — factor loadings, relative strength, drawdowns, risk-adjusted history, and factor-similar peers. Statistical estimates are descriptive, not forecasts.
• Hand-built market values: 1,276,308,057 filing shares at $64.14 = approximately $81.86B equity value; approximately $21.45B debt less $1.716B cash = $19.73B net debt; enterprise value approximately $101.6B.
• AZI valuation-index limitation: the fundamentals endpoint could not be refreshed because AZI_API_TOKEN was unavailable. The June 12, 2026 own-history read—P/E 89.2nd percentile, P/B 85.0th, P/S 21.5th, composite 65.2nd—is included only when explicitly dated and with the warning that GAAP P/E is cocoa/derivative distorted.

5. Public peer and transaction context

• Hershey, PepsiCo, General Mills, Kraft Heinz, Campbell’s, J.M. Smucker, Nestlé, Mars, and Ferrero public filings and company releases provide category, pricing, retailer, cocoa, and capital-cycle cross-checks.
• Public reporting and company/SEC disclosures concerning the 2016 and 2024 Hershey approaches, the December 2024 repurchase authorization, the developed-market gum sale, and the JDE Peet’s exit provide transaction context. No ownership conclusion is inferred.